A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma

NCT01613313 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDIV

Sponsor class

Conditions

Lipoma

Interventions

DRUG: Collagenase Clostridium Histolyticum

Sponsor

Zachary Gerut

Collaborators

[object Object]